Modular Medical Teams Up with Nudge BG in Exciting Licensing and Partnership Deal!
Description:
Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements. The effort will be led by Nudge BG founder and noted AID expert, Lane Desborough.
SAN DIEGO, CA / ACCESSWIRE / December 19, 2024 – Modular Medical, Inc. (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of “almost-pumpers” with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG.
Blog Post Article:
Exciting news in the world of medical technology! Modular Medical, known for its innovative insulin delivery solutions, has joined forces with Nudge BG to bring a groundbreaking Automated Insulin Delivery system to market. This revolutionary system is a full closed loop solution that eliminates the need for mealtime announcements, providing a seamless and adaptive experience for users.
The partnership between Modular Medical and Nudge BG is set to redefine the way automated insulin delivery is approached. With Lane Desborough, a recognized expert in the field of AID, at the helm, the collaboration promises to deliver a new standard in insulin delivery technology.
Modular Medical’s FDA-cleared patch pump has already made waves in the industry for its user-friendly design and affordability, catering to the needs of those who require insulin but may not be using traditional insulin pump therapy.
With this new licensing and partnership agreement, both companies are poised to make a significant impact on the medical technology landscape. The combination of Modular Medical’s expertise in insulin delivery and Nudge BG’s innovative approach to AID promises to bring about a shift in how diabetes management is approached.
How will this affect me?
As a consumer, this partnership could potentially offer you a more streamlined and efficient automated insulin delivery system. The closed loop design with no mealtime announcements could make managing diabetes easier and more discreet.
How will this affect the world?
This collaboration has the potential to set a new standard in automated insulin delivery technology, impacting the way diabetes is managed on a global scale. By offering a more user-friendly and adaptive solution, this partnership could improve the quality of life for individuals living with diabetes worldwide.
Conclusion:
The partnership between Modular Medical and Nudge BG represents a significant milestone in the field of medical technology. By bringing to market an advanced Automated Insulin Delivery system, both companies are poised to make a transformative impact on the lives of individuals living with diabetes. This collaboration heralds a new era in insulin delivery technology, promising a more user-friendly and efficient solution for managing diabetes.